Biotechnology in Argentina: Development and Resources
Requires Subscription or Fee PDF


research and development


Biotechnology related developments in Argentina have gained momentum in the past few years. The creation of the Ministry of Science, Technology and Innovative Production in 2007 that focuses on high-tech growth in technology related fields including biotechnology, demonstrates the public sector commitment to a field with a thriving business sector and promising improvements in research and development. By embracing its agricultural advantage and investing in research and innovation, Argentina has seen its stock of biotech companies grow to 120, of which 90 percent are domestic small and medium size. Today, biotechnology researchers in Argentina engage in international collaboration with other scholars and globally recognized institutions and the country has bilateral agreements with other countries to support biotechnology related research and development. There are many governmental and non-profit organizations that are influential in shaping Argentina’s vision on biotechnology. Although the government places importance in providing support in biotechnology research, innovation and investment, the paper argues that the rapid growth trends in the industry requires biotechnology to become higher on the national agenda. The lack of a royalty collection system, the absence of patent protection, and the inadequate sources of venture capital still remain as important problems. Attracting new forms of foreign capital, higher investment in infrastructure, building on existing regional and global networks in research and development, are all important areas for improvement to advance biotechnology in Argentina.
Requires Subscription or Fee PDF


Gutman, G., Lavarello, P. and Cajal J. (2006) La biotecnología y las industrias de ingredientes alimentarios en Argentina. Journal of Technology Management & Innovation, I(3): 121-130.

Guillermo, A., Bisang, R. and Stubrin, L. (2010) Las empresas de biotecnología en Argentina. UN: CEPAL - Coleccion Documentos de Proyectos. December 2010.

Ferrand, Y., Kelton, C.M.L., Chen, K., and Stafford, H.A. (2009) Biotechnology in Cincinnati: Clustering or Colocation? Economic Development Quarterly. 23 (2): 127-140.

Gertler, M.S. and Vindorai, T. (2009) Life Sciences and Regional Innovation: One Path or Many? European Planning Studies. 17 (2): 235-261.

Sherwin, S. (2011) Dr. Stephen Sherwin, BIO Chairman and Chairman & Co-founder of Ceregene, Addresses Attendees at BIO International Convention. (accessed October 2011).

Ernst&Young. (2011) Beyond Borders: Global Biotechnology Report 2011.$FILE/Beyond_borders_global_biotechnology_report_2011.pdf (accessed October 2011).

Biotech-Tailor-made for Israel. (accessed October 2011).

Randall, J. (2000) Despite Embargo, Biotechnology in Cuba Thrives. JNCI J Natl Cancer Inst 92 (13): 1034-1037.

ProsperAR. (2009) Biotechnology in Argentina: Knowledge + Innovation to meet global market needs. (accessed October 2011).

USDA. (2010) Argentina: Biotechnology GE Plants and Animals 2010 Annual Biotechnology Report. (accessed October 2011).

Science and Technology; Perspective of Argentina’s Government. Presentation by Alejandro Ceccatto Deputy Minister of ST&I. (accessed October 2011).

BIOTECSUR. (2008) Inventory of Biotechnological Rules and Regulations in the MERCOSUR. (accessed October 2011).

Data Source: ProsperAR. (2009) Biotechnology in Argentina: Knowledge + Innovation to meet global market needs. (accessed October 2011).

Data Source: BIOTECSUR. (2008) Inventory of Biotechnology Capacities. (accessed October 2011).

Richards, D.G. (2010) Contradictions of the ‘New Green Revolution’: A View from South America's Southern Cone. Globalizations, 7(4): 563-576.

Argentina Israel Cooperation Program. (accessed October 2011).

Battelle. (2011) 2011 Global R&D Funding Forecast. (accessed October 2011).

Data Source: Battelle. (2011) 2011 Global R&D Funding Forecast. (accessed October 2011).

BIOTECSUR (2008) Inventory of Biotechnology Capacities. (accessed October 2011).

FONCyT. (accessed November 2011).

FONARSEC. (accessed November 2011).

ORGANIGRAMA. (accessed November 2011)

CONICET. (accessed October 2011).

The National Agency for the Promotion of Science and Technology of Argentina (ANPCYT) - Biotecnology 2005: Patents for SMEs Grant Call. (accessed November 2011).

ARGEN BIO. (accessed October 2011).

FAB. (accessed October 2011).

CEBIGEVE. (accessed October 2011).

Polo Cientifico Tecnologico. (accessed November 2011).

Erber, F.S. (1999) Structural Reforms and Science and Technology Policies in Argentina and Brazil. Paper prepared for the seminar "Políticas para fortalecer el Sistema Nacional de Innovación: La experiencia internacional y el camino empreendido por la Argentina", organised by the Secretaria de Ciencia y Tecnologia, Buenos Aires, September. (accessed October 2011).

BIOTECSUR. (accessed October 2011).

CABBIO. (accessed October 2011).

Lanteri, L. (2008) Argentina’s Soybean Acreage Response to Changes in Price Incentives. Central Bank of Argentina, Economic Essays. 52 (October-December).

Manfroni, M. (2010) La soja BT RR ya está madura, pero sigue en lista de espera. La Nacion 17 April. (accessed December 2011)

"Beneficios de la Introducción de Nuevas Tecnologias de Soja" Seminario de la Asociasion Semilleros Argentinos, 12/7/2011 en Buenos Aires (accessed December 2011)

Kesan, J.P. and Gallo, A.A. (2005) Property rights and incentives to invest in seed varieties: Governmental regulations in Argentina. AgBioForum. 8(2&3): 118-126.

The Economist (2011) Cristina Prepares to Defy Gravity. 17 December. (accessed December 2011)

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.